V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 310007955 | 310005114 | 1.86 | 60.8 | Palliative (P) | 2018-02-24 | 2018-03-27 | DOXORUBICIN | 02 | null | 310020148 | FLUDARABINE + MELPHALAN |
| 310007956 | 310005115 | null | null | Palliative (P) | 2016-05-20 | 2016-05-21 | Oxaliplatin + Modified de Gramont | 2 | N | 310020155 | CISPLATIN + GEMCITABINE + RITUXIMAB |
| 310007957 | 310009890 | null | 70.8 | null | 2016-06-13 | 2016-06-20 | Lenalidomide 25mg (Cycle 1 to 25) | N | N | 310020155 | IMATINIB |
| 310007958 | 310005116 | 1.59 | 66.9 | Adjuvant (A) | 2016-04-19 | 2016-04-20 | Capecitabine | N | N | 310020159 | LANREOTIDE |
| 310007959 | 310005116 | 1.73 | 63 | Palliative (P) | 2014-12-15 | 2014-12-22 | Everolimus 10mg | 02 | N | 310020159 | CHLORAMBUCIL + DEXAMETHASONE + ETOPOSIDE |
| 310007960 | 310005120 | null | 59.3 | Curative (C) | 2014-11-24 | 2014-12-19 | Methotrexate High Dose (3g/m2) | N | N | 310020170 | TRASTUZUMAB |
| 310007961 | 310009891 | 1.91 | 38.6 | Palliative (P) | 2013-03-23 | 2013-03-23 | Methotrexate + Folinic acid | 02 | N | 310020170 | ALEMTUZUMAB + FLUDARABINE + MELPHALAN |
| 310007963 | 310005126 | null | 83.3 | Palliative (P) | 2014-01-13 | 2014-01-13 | Imatinib 400mg | N | N | 310020176 | BLEOMYCIN + CARBOPLATIN + ETOPOSIDE |
| 310007964 | 310005128 | null | 75 | Adjuvant (A) | 2016-11-30 | 2016-12-14 | GEMCITABINE + VINORELBINE | N | N | 310020177 | CISPLATIN + DACTINOMYCIN + ETOPOSIDE + METHOTREXATE |
| 310007965 | 310008244 | 0 | null | Adjuvant (A) | 2013-08-12 | 2013-12-18 | Mitotane 3 - 3.5g | N | N | 310020177 | BCG |
| 310007966 | 310008245 | 0 | 69 | Adjuvant (A) | 2014-06-22 | 2014-06-22 | INCA TRIAL | N | N | 310020187 | ICE-R |
| 310007967 | 310005132 | null | 66.5 | null | 2016-08-20 | 2016-08-23 | DHAP - R | 02 | null | 310020191 | CYCLOPHOSPHAMIDE + DOXORUBICIN + ETOPOSIDE + VINCRISTINE |
| 310007968 | 310005134 | 1.73 | null | null | 2016-08-20 | 2016-08-20 | Cetuximab 7 day (Cycle 1) | null | Y | 310020192 | VEMURAFENIB |
| 310007969 | 310005134 | 1.75 | 71 | Palliative (P) | 2015-09-19 | 2015-09-23 | DA-EPOCH-R | N | N | 310020192 | IVA |
| 310007975 | 310008248 | null | null | Curative (C) | 2017-06-13 | 2017-06-24 | INTERFERON | 02 | N | 310020217 | MELPHALAN |
| 310007976 | 310008248 | 1.76 | 60 | Palliative (P) | 2014-08-01 | 2014-08-05 | DHAP | N | N | 310020217 | DABRAFENIB |
| 310007977 | 310005138 | 1.44 | 61.3 | Palliative (P) | 2016-07-30 | 2016-08-27 | ECX | 2 | null | 310020227 | CETUXIMAB |
| 310007978 | 310009898 | 1.82 | 0 | Palliative (P) | 2013-12-22 | 2015-03-10 | VEDex | null | N | 310020229 | VEMURAFENIB |
| 310007979 | 310005140 | 1.5 | 69.7 | Curative (C) | 2015-09-15 | 2015-10-19 | STS Rhabdomyosarcoma RMS 2005 IVA | 02 | N | 310020230 | DHAP - R |
| 310007980 | 310010789 | null | null | Palliative (P) | 2015-06-22 | 2015-09-21 | Chlorambucil | N | null | 310020230 | OXALIPLATIN + MDG |
| 310007981 | 310010789 | null | 80.7 | Palliative (P) | 2016-12-28 | 2016-12-28 | Trastuzumab 21 day loading dose | 02 | N | 310020230 | CHLORAMBUCIL + DEXAMETHASONE + ETOPOSIDE |
| 310007982 | 310005141 | 1.6 | 96 | Curative (C) | 2013-10-05 | 2013-11-10 | CHOEP - 14 days | 02 | N | 310020245 | CAPECITABINE + CISPLATIN |
| 310007983 | 310005141 | 1.69 | null | Palliative (P) | 2018-09-02 | 2018-09-25 | Capecitabine + Oxaliplatin 21day | Y | N | 310020245 | GEMCITABINE + OXALIPLATIN |
| 310007984 | 310005143 | 1.5 | 63.3 | Curative (C) | 2015-11-06 | 2015-11-06 | Gemcitabine + Oxaliplatin | N | N | 310020253 | VEMURAFENIB |
| 310007985 | 310005144 | 1.57 | 52 | Palliative (P) | 2017-07-02 | 2017-07-10 | Topotecan (intravenous) | 2 | N | 310020267 | IVE + METHOTREXATE |
| 310007986 | 310005145 | 1.5 | 44.2 | Palliative (P) | 2017-01-29 | 2017-03-07 | Niraparib | 2 | N | 310020267 | OXALIPLATIN + MDG |
| 310007987 | 310005146 | 0 | 60.4 | null | 2013-08-11 | 2013-08-11 | DOXORUBICIN | null | null | 310020268 | AZACITIDINE |
| 310007988 | 310005149 | null | 92.2 | Curative (C) | 2015-03-07 | 2015-03-30 | Thalidomide 100mg | N | N | 310020281 | IMATINIB |
| 310007989 | 310005150 | null | 90.5 | Adjuvant (A) | 2013-11-11 | 2013-11-12 | CETUXIMAB + RT | N | N | 310020286 | CVP R |
| 310007990 | 310005151 | 1.76 | 110 | Curative (C) | 2013-12-22 | 2013-12-22 | Epirubicin | N | N | 310020287 | ICON TRIAL |
| 310007991 | 310008254 | 1.72 | 59.8 | Palliative (P) | 2016-03-05 | 2016-03-15 | Cyclophosphamide+Fludara+TBI Allo | 2 | N | 310020845 | CYCLOPHOSPHAMIDE + FLUDARABINE |
| 310007992 | 310008254 | 1.62 | 104.8 | Palliative (P) | 2016-12-10 | 2016-12-10 | Vemurafenib | N | N | 310020845 | GEMCITABINE + OXALIPLATIN |
| 310007993 | 310005154 | 1.62 | 10.7 | Palliative (P) | 2015-05-18 | 2015-05-29 | LANREOTIDE | 2 | N | 310021556 | CAPECITABINE |
| 310007994 | 310005154 | 1.74 | 68.5 | Curative (C) | 2016-10-09 | 2016-12-05 | CARMUSTINE + THIOTEPA | N | N | 310021556 | PEMETREXED |
| 310007995 | 310005154 | 1.75 | 61.9 | Adjuvant (A) | null | 2015-04-11 | Topotecan (oral) | N | N | 310021556 | METHOTREXATE |
| 310007996 | 310005154 | 1.6 | 61 | Adjuvant (A) | 2018-10-27 | 2018-12-20 | Sunitinib | 02 | Y | 310021556 | CHOEP |
| 310007997 | 310005155 | 1.65 | 75 | Curative (C) | 2014-03-14 | 2014-04-11 | CYCLOPHOSPHAMIDE + VINBLASTINE | N | N | 310023156 | IBRUTINIB |
| 310007998 | 310005156 | 1.77 | 53.8 | Palliative (P) | 2013-12-25 | 2014-08-17 | STS Rhabdomyosarcoma RMS 2005 IVA | N | N | 310023158 | CYCLOPHOSPHAMIDE + FLUDARABINE |
| 310007999 | 310008256 | 1.8 | null | Palliative (P) | 2013-12-03 | 2013-12-03 | Abiraterone | 02 | N | 310023172 | TEMOZOLOMIDE |
| 310008000 | 310005157 | 1.2 | 69.7 | Palliative (P) | 2015-05-22 | 2015-06-19 | Carboplatin + Docetaxel | 2 | N | 310023182 | CYCLOPHOSPHAMIDE + VINORELBINE |
| 310008001 | 310005158 | 1.72 | null | Palliative (P) | 2014-06-19 | 2014-07-02 | Trabectedin | 02 | null | 310023183 | DOXORUBICIN |
| 310008002 | 310005159 | 1.68 | null | Disease modification (D) | 2018-05-29 | 2018-05-29 | ICON8 TRIAL | null | null | 310023183 | CTD |
| 310008003 | 310005160 | 1.53 | 71 | null | 2015-01-03 | 2015-02-08 | Everolimus 10mg | N | N | 310023198 | DHAX - R |
| 310008004 | 310005160 | 0 | 59 | Palliative (P) | 2014-05-06 | 2014-05-06 | DABRAFENIB + TRAMETINIB | N | N | 310023198 | TEMOZOLOMIDE |
| 310008005 | 310005160 | null | 67.3 | Curative (C) | 2014-07-24 | 2014-07-24 | BEAM + Alemtuzumab Allo SCT | 01 | N | 310023198 | ICE |
| 310008006 | 310005160 | 1.66 | 61 | Palliative (P) | 2015-08-03 | 2015-08-10 | BENDAMUSTINE + CYTARABINE + ETOPOSIDE + MELPHALAN | N | N | 310023198 | TRASTUZUMAB |
| 310008007 | 310005161 | 1.69 | 83 | Palliative (P) | 2014-06-23 | 2014-06-24 | CARBOPLATIN + Cetuximab + FLUOROURACIL | N | N | 310023225 | VEDEX |
| 310008008 | 310005162 | 0 | 77 | Curative (C) | 2013-11-26 | 2013-11-27 | INTERFERON | N | null | 310023229 | TEMOZOLOMIDE |
| 310008009 | 310009904 | 1.78 | 43.2 | Curative (C) | 2017-02-23 | 2017-02-23 | Carboplatin + Pemetrexed | null | N | 310023229 | IRINOTECAN + MDG |
| 310008010 | 310005164 | 1.65 | 82.9 | Palliative (P) | 2017-10-26 | 2017-10-28 | ECarboX | 2 | N | 310023238 | ECF |